Loading...

Gary S Leiserowitz

Title(s)Professor, Obstetrics and Gynecology
SchoolUniversity of California, Davis
Phone916-734-6938
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Miyamoto S, Stroble CD, Taylor S, Hong Q, Lebrilla CB, Leiserowitz GS, Kim K, Ruhaak LR. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer. J Proteome Res. 2018 01 05; 17(1):222-233. PMID: 29207246.
      View in: PubMed
    2. Girda E, Huang EC, Leiserowitz GS, Smith LH. The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible. Int J Gynecol Cancer. 2017 10; 27(8):1701-1707. PMID: 28683005.
      View in: PubMed
    3. Nielsen AA, Liyanage TA, Leiserowitz GS, Mayadev J. Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy. J Contemp Brachytherapy. 2017 Jun; 9(3):216-223. PMID: 28725244.
      View in: PubMed
    4. Leiserowitz GS, Lin JF, Tergas AI, Cliby WA, Bristow RE. Factors Predicting Use of Neoadjuvant Chemotherapy Compared With Primary Debulking Surgery in Advanced Stage Ovarian Cancer-A National Cancer Database Study. Int J Gynecol Cancer. 2017 05; 27(4):675-683. PMID: 28328580.
      View in: PubMed
    5. Carney RP, Hazari S, Colquhoun M, Tran D, Hwang B, Mulligan MS, Bryers JD, Girda E, Leiserowitz GS, Smith ZJ, Lam KS. Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations. Anal Chem. 2017 05 16; 89(10):5357-5363. PMID: 28345878.
      View in: PubMed
    6. Miyamoto S, Ruhaak LR, Stroble C, Salemi MR, Phinney B, Lebrilla CB, Leiserowitz GS. Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides. J Proteome Res. 2016 09 02; 15(9):3358-76. PMID: 27500424.
      View in: PubMed
    7. Wallace SK, Lin JF, Cliby WA, Leiserowitz GS, Tergas AI, Bristow RE. Refusal of Recommended Chemotherapy for Ovarian Cancer: Risk Factors and Outcomes; a National Cancer Data Base Study. J Natl Compr Canc Netw. 2016 05; 14(5):539-50. PMID: 27160232.
      View in: PubMed
    8. Ruhaak LR, Kim K, Stroble C, Taylor SL, Hong Q, Miyamoto S, Lebrilla CB, Leiserowitz G. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients. J Proteome Res. 2016 Mar 04; 15(3):1002-10. PMID: 26813784.
      View in: PubMed
    9. Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer. Obstet Gynecol. 2015 Sep; 126(3):491-7. PMID: 26244529.
      View in: PubMed
    10. Kennedy VA, Leiserowitz GS. Preserving sexual function in women and girls with cancer: survivorship is about more than just surviving. Am J Obstet Gynecol. 2015 Aug; 213(2):119-20. PMID: 26216177.
      View in: PubMed
    11. Huddleston A, Zhen S, Qi L, Rash D, Leiserowitz G, Mayadev J. The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer. J Contemp Brachytherapy. 2015 Apr; 7(2):122-7. PMID: 26034492.
      View in: PubMed
    12. Kim K, Ruhaak LR, Nguyen UT, Taylor SL, Dimapasoc L, Williams C, Stroble C, Ozcan S, Miyamoto S, Lebrilla CB, Leiserowitz GS. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):611-21. PMID: 24557531.
      View in: PubMed
    13. Taylor SL, Leiserowitz GS, Kim K. Accounting for undetected compounds in statistical analyses of mass spectrometry 'omic studies. Stat Appl Genet Mol Biol. 2013 Dec; 12(6):703-22. PMID: 24246290.
      View in: PubMed
    14. Ruhaak LR, Taylor SL, Miyamoto S, Kelly K, Leiserowitz GS, Gandara D, Lebrilla CB, Kim K. Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses. Anal Bioanal Chem. 2013 May; 405(14):4953-8. PMID: 23525540.
      View in: PubMed
    15. Hua S, Williams CC, Dimapasoc LM, Ro GS, Ozcan S, Miyamoto S, Lebrilla CB, An HJ, Leiserowitz GS. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A. 2013 Mar 01; 1279:58-67. PMID: 23380366.
      View in: PubMed
    16. Kronewitter SR, De Leoz ML, Strum JS, An HJ, Dimapasoc LM, Guerrero A, Miyamoto S, Lebrilla CB, Leiserowitz GS. The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. Proteomics. 2012 Aug; 12(15-16):2523-38. PMID: 22903841.
      View in: PubMed
    17. Rodriguez AO, Gonik AM, Zhou H, Leiserowitz GS, White RH. Venous thromboembolism in uterine cancer. Int J Gynecol Cancer. 2011 Jul; 21(5):870-6. PMID: 21666485.
      View in: PubMed
    18. Cress RD, Bauer K, O'Malley CD, Kahn AR, Schymura MJ, Wike JM, Stewart SL, Leiserowitz GS. Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study. Gynecol Oncol. 2011 Apr; 121(1):94-9. PMID: 21256581.
      View in: PubMed
    19. Kronewitter SR, de Leoz ML, Peacock KS, McBride KR, An HJ, Miyamoto S, Leiserowitz GS, Lebrilla CB. Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J Proteome Res. 2010 Oct 01; 9(10):4952-9. PMID: 20698584.
      View in: PubMed
    20. Leiserowitz GS, Xing G, Parikh-Patel A, Cress R, Abidi A, Rodriguez AO, Dalrymple JL. Laparoscopic versus abdominal hysterectomy for endometrial cancer: comparison of patient outcomes. Int J Gynecol Cancer. 2009 Nov; 19(8):1370-6. PMID: 20009892.
      View in: PubMed
    21. Kronewitter SR, An HJ, de Leoz ML, Lebrilla CB, Miyamoto S, Leiserowitz GS. The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics. 2009 Jun; 9(11):2986-94. PMID: 19452454.
      View in: PubMed
    22. Barkauskas DA, An HJ, Kronewitter SR, de Leoz ML, Chew HK, de Vere White RW, Leiserowitz GS, Miyamoto S, Lebrilla CB, Rocke DM. Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics. 2009 Jan 15; 25(2):251-7. PMID: 19073586.
      View in: PubMed
    23. Guiou M, Hall WH, Konia T, Scudder S, Leiserowitz G, Ryu JK. Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):1118-21. PMID: 17986241.
      View in: PubMed
    24. Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):95-9. PMID: 17949796.
      View in: PubMed
    25. Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, Li B, Liu H, Lam KS. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer. 2008 May-Jun; 18(3):470-5. PMID: 17655680.
      View in: PubMed
    26. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007 Jun; 109(6):1342-50. PMID: 17540806.
      View in: PubMed
    27. Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, Teng NN, Kapp DS, Berek JS, Leiserowitz GS. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer. 2006 Nov 20; 95(10):1314-20. PMID: 17088903.
      View in: PubMed
    28. Leiserowitz GS. Managing ovarian masses during pregnancy. Obstet Gynecol Surv. 2006 Jul; 61(7):463-70. PMID: 16787549.
      View in: PubMed
    29. An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS, Leiserowitz GS, Lebrilla CB. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res. 2006 Jul; 5(7):1626-35. PMID: 16823970.
      View in: PubMed
    30. Elliott KS, Borowsky ME, Malka ES, Scudder SA, Leiserowitz GS, Russell AH. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients. J Reprod Med. 2006 May; 51(5):383-8. PMID: 16779984.
      View in: PubMed
    31. Leiserowitz GS, Xing G, Cress R, Brahmbhatt B, Dalrymple JL, Smith LH. Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol. 2006 May; 101(2):315-21. PMID: 16310839.
      View in: PubMed
    32. Rodriguez AO, Truskinovsky AM, Kasrazadeh M, Leiserowitz GS. Case report: Malignant peripheral nerve sheath tumor of the uterine cervix treated with radical vaginal trachelectomy. Gynecol Oncol. 2006 Jan; 100(1):201-4. PMID: 16182351.
      View in: PubMed
    33. Dalrymple JL, Gilbert WM, Leiserowitz GS, Cress R, Xing G, Danielsen B, Smith LH. Pregnancy-associated cervical cancer: obstetric outcomes. J Matern Fetal Neonatal Med. 2005 Apr; 17(4):269-76. PMID: 16147836.
      View in: PubMed
    34. Dalrymple JL, Russell AH, Lee SW, Scudder SA, Leiserowitz GS, Kinney WK, Smith LH. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer. 2004 Jan-Feb; 14(1):110-7. PMID: 14764038.
      View in: PubMed
    35. O'Malley CD, Cress RD, Campleman SL, Leiserowitz GS. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol Oncol. 2003 Dec; 91(3):608-15. PMID: 14675685.
      View in: PubMed
    36. Leiserowitz GS, Gumbs JL, Oi R, Dalrymple JL, Smith LH, Ryu J, Scudder S, Russell AH. Endometriosis-related malignancies. Int J Gynecol Cancer. 2003 Jul-Aug; 13(4):466-71. PMID: 12911723.
      View in: PubMed
    37. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol. 2003 Apr 15; 21(8):1530-5. PMID: 12697877.
      View in: PubMed
    38. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilbert WM. Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997. Am J Obstet Gynecol. 2001 Jun; 184(7):1504-12; discussion 1512-3. PMID: 11408874.
      View in: PubMed
    39. Wong AW, Leiserowitz GS, McCausland VM, McCausland AM. Catamenial fevers associated with a uterine smooth muscle tumor of undetermined malignant potential. Obstet Gynecol. 1998 Oct; 92(4 Pt 2):671-2. PMID: 9764658.
      View in: PubMed
    40. Leiserowitz GS, Russell AH, Kinney WK, Smith LH, Taylor MH, Scudder SA. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol. 1997 Sep; 66(3):509-14. PMID: 9299268.
      View in: PubMed
    41. Leiserowitz GS, Hall KS, Foster CA, Hitchcock ME, Christensen ND, Heim K, Smith LH. Detection of serologic neutralizing antibodies against HPV-11 in patients with condyloma acuminata and cervical dysplasia using an in vitro assay. Gynecol Oncol. 1997 Aug; 66(2):295-9. PMID: 9264579.
      View in: PubMed
    42. Christensen ND, Reed CA, Cladel NM, Hall K, Leiserowitz GS. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology. 1996 Oct 15; 224(2):477-86. PMID: 8874508.
      View in: PubMed
    43. Leiserowitz GS, Webb MJ. Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction. Obstet Gynecol. 1996 Oct; 88(4 Pt 2):696-9. PMID: 8841257.
      View in: PubMed
    44. Smith LH, Foster C, Hitchcock ME, Leiserowitz GS, Hall K, Isseroff R, Christensen ND, Kreider JW. Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J Invest Dermatol. 1995 Sep; 105(3):438-44. PMID: 7665926.
      View in: PubMed
    45. Leiserowitz GS, Harris SA, Subramaniam M, Keeney GL, Podratz KC, Spelsberg TC. The proto-oncogene c-fms is overexpressed in endometrial cancer. Gynecol Oncol. 1993 May; 49(2):190-6. PMID: 8504987.
      View in: PubMed
    46. Leiserowitz GS, Evans AT, Samuels SJ, Omand K, Kost GJ. Creatine kinase and its MB isoenzyme in the third trimester and the peripartum period. J Reprod Med. 1992 Nov; 37(11):910-6. PMID: 1460608.
      View in: PubMed